REFERENCES
- Alter BP, Young NS. The bone marrow failure syndrome. In: Nathan DG, Orkin SH, eds. Nathan and Oski’s Hematology of Infancy and Childhood, ed 5. Philadelphia: WB Saunders; 1998:237-335.
- Best WR. Drug-associated blood dyscrasias: recent additions to the registry. JAMA. 1963;185:286- 291.
- The International Agranulocytosis and Aplastic Anemia Study. Risk of agranulocytosis and aplas-tic anemia: a first report of their relation to drug use with special reference to analgesics. JAMA. 1986;256:1749-1757.
- Kewitz H. Rare but serious risks associated with non-narcotic analgesics: clinical experience. Med Toxicol 1986;1(suppl 1):86-92.
- Kaufman DW, Kelly JP, Jurgelon JM, et al. Drugs in the aetiology of agranulocytosis and aplastic anemia. Eur J Haematol 1996;57(suppl):23-30.
- Andrade SE, Martinez C, Walker AM. Comparative safety evaluation of non-narcotic analgesics. J Clin Epidemiol 1998;51:1357-1365.
- Heit WF. Hematologic effects of antipyretic analgesics: drug-induced agranulocytosis. Am J Med. 1983;75:65-69.
- Shapiro S, Issaragrisil S, Kaufman DW, et al. Aplastic Anemia Study Group. Agranulocytosis in Bangkok, Thailand: a predominantly drug-induced disease with an unusually low incidence. Am J Trop Med Hyg. 1999;60:573-577.
- Alnigenis MN, Nalcaci M, Pekcelen Y, Atamer T, Sargin D. Possible etiologic factors in 151 Turkish patients with aplastic anemia. Am JHematol 2001;68:60-65.
- Guess HA. Behavior of the odds ratio in a case-control study when the hazard function is not constant over time. J Clin Epidemiol 1989;42:1179-1184.
- Ozsoylu S. High dose intravenous methylprednisolone (HIVMP) in hematologic disorders. Hematol Rev. 1990;4:197-207.
- Yetgin S, Gurgey A, Tuncer AM, et al. A comparison of the effect of high dose methylprednisolone in acute lymphoblastic leukemia patients with randomization. LeukRes. 1998;22:485-493.
- Yetgin S, Cetin M. The dose related effect of steroids on blast reduction rate and event free survival in children with acute lymphoblastic leukemia. Leuk Lymphoma. 2003;44:89-95.
- Yetgin S, Tuncer MA, Cetin M, et al. Benefit of high-dose methylprednisolone in comparison with conventional-dose prednisolone during remission induction therapy in childhood acute lymphoblastic leukemia for long term follow-up. Leukemia. 2003;17:328-333.
- Ozbek N, Yetgin S, Tuncer AM. Effects of G-CSF and high-dose methylprednisolone on peripheral stem cell, serum IL-3 levels and hematological parameters in acute lymphoblastic leukemia patients with neutropenia: a pilot study. LeukRes. 2000;24: 55-58.
- Ozbek N, Yetgin S, Tuncer AM. Effect of high-dose methylprednisolone and G-CSF treatment on lymphocyte subtypes in neutropenic children with acute lymphoblastic leukemia: a pilot study. Pediatr Hematol Oncol. 1998;15:539-544.
- Cetin M, Hicsonmez G, Tuncer AM, Kansu E, Canpinar H. The effect of short course high-dose corticosteroid therapy on peripheral blood CD34+ progenitor cells in children with acute lymphoblastic leukemia. Exp Hematol 1996;24:1191-1194.
- Taher A, Ammash Z, Dabajah B, Nasrallah A, Mourad FH. Ticlopidine induced aplastic anemia and quick recovery with G-CSF: report and literature review. Am J Hematol 2000;63:90-93.